I-neb AAD System

Battery-powered drug delivery device

Find similar products

The I-neb is a small, battery powered, lightweight and virtually silent drug delivery device. It significantly reduces the inconvenience of conventional nebulizer/compressor therapy while delivering a precise, reproducible dose.

Features
Adaptive Aerosol Delivery system

Adaptive Aerosol Delivery system optimizes drug delivery

This technology ensures optimal drug delivery by only delivering medication when the patient inhales. This gives the medication the best opportunity to reach deep into the lungs and greatly reduces waste to the environment. AAD delivers the right amount of medication, regardless of size or breathing patterns.

Adaptive Aerosol Delivery system optimizes drug delivery

This technology ensures optimal drug delivery by only delivering medication when the patient inhales. This gives the medication the best opportunity to reach deep into the lungs and greatly reduces waste to the environment. AAD delivers the right amount of medication, regardless of size or breathing patterns.

Adaptive Aerosol Delivery system optimizes drug delivery

This technology ensures optimal drug delivery by only delivering medication when the patient inhales. This gives the medication the best opportunity to reach deep into the lungs and greatly reduces waste to the environment. AAD delivers the right amount of medication, regardless of size or breathing patterns.
Small and lightweight

Small and lightweight for full portability

Small and lightweight for full portability

Small and lightweight for full portability

Vibrating mesh technology

Vibrating mesh technology generates fine-particle aerosol

This technology produces a fine-particle, low-velocity aerosol by forcing the liquid medication through a fine mesh. Faster than conventional jet or ultrasonic nebulizers, VMT devices support shorter treatment times and more precise drug delivery.

Vibrating mesh technology generates fine-particle aerosol

This technology produces a fine-particle, low-velocity aerosol by forcing the liquid medication through a fine mesh. Faster than conventional jet or ultrasonic nebulizers, VMT devices support shorter treatment times and more precise drug delivery.

Vibrating mesh technology generates fine-particle aerosol

This technology produces a fine-particle, low-velocity aerosol by forcing the liquid medication through a fine mesh. Faster than conventional jet or ultrasonic nebulizers, VMT devices support shorter treatment times and more precise drug delivery.
Long battery life

Long battery life leaves patients free to plan their day

The I-neb is battery-powered with a universal voltage charger. The long battery life provides up to 40 treatments per charge, for freedom and convenience.

Long battery life leaves patients free to plan their day

The I-neb is battery-powered with a universal voltage charger. The long battery life provides up to 40 treatments per charge, for freedom and convenience.

Long battery life leaves patients free to plan their day

The I-neb is battery-powered with a universal voltage charger. The long battery life provides up to 40 treatments per charge, for freedom and convenience.
Specific metering chambers

Specific metering chambers for dosage control

The metering chambers with volumes ranging from 0.25 to 1.7 ml with a residual of about 0.15 ml. This optimizes treatment while reducing waste.

Specific metering chambers for dosage control

The metering chambers with volumes ranging from 0.25 to 1.7 ml with a residual of about 0.15 ml. This optimizes treatment while reducing waste.

Specific metering chambers for dosage control

The metering chambers with volumes ranging from 0.25 to 1.7 ml with a residual of about 0.15 ml. This optimizes treatment while reducing waste.
AAD algorithm

AAD algorithm for adaptive treatment

The I-neb pulses medication delivery into 50 to 80% of each inspiration, based on a rolling average of the last three breaths. Throughout the treatment, the I-neb provides continuous feedback to the patient. Upon successful delivery, the patient receives audible and tactile feedback.

AAD algorithm for adaptive treatment

The I-neb pulses medication delivery into 50 to 80% of each inspiration, based on a rolling average of the last three breaths. Throughout the treatment, the I-neb provides continuous feedback to the patient. Upon successful delivery, the patient receives audible and tactile feedback.

AAD algorithm for adaptive treatment

The I-neb pulses medication delivery into 50 to 80% of each inspiration, based on a rolling average of the last three breaths. Throughout the treatment, the I-neb provides continuous feedback to the patient. Upon successful delivery, the patient receives audible and tactile feedback.
  • Adaptive Aerosol Delivery system
  • Small and lightweight
  • Vibrating mesh technology
  • Long battery life
See all features
Adaptive Aerosol Delivery system

Adaptive Aerosol Delivery system optimizes drug delivery

This technology ensures optimal drug delivery by only delivering medication when the patient inhales. This gives the medication the best opportunity to reach deep into the lungs and greatly reduces waste to the environment. AAD delivers the right amount of medication, regardless of size or breathing patterns.

Adaptive Aerosol Delivery system optimizes drug delivery

This technology ensures optimal drug delivery by only delivering medication when the patient inhales. This gives the medication the best opportunity to reach deep into the lungs and greatly reduces waste to the environment. AAD delivers the right amount of medication, regardless of size or breathing patterns.

Adaptive Aerosol Delivery system optimizes drug delivery

This technology ensures optimal drug delivery by only delivering medication when the patient inhales. This gives the medication the best opportunity to reach deep into the lungs and greatly reduces waste to the environment. AAD delivers the right amount of medication, regardless of size or breathing patterns.
Small and lightweight

Small and lightweight for full portability

Small and lightweight for full portability

Small and lightweight for full portability

Vibrating mesh technology

Vibrating mesh technology generates fine-particle aerosol

This technology produces a fine-particle, low-velocity aerosol by forcing the liquid medication through a fine mesh. Faster than conventional jet or ultrasonic nebulizers, VMT devices support shorter treatment times and more precise drug delivery.

Vibrating mesh technology generates fine-particle aerosol

This technology produces a fine-particle, low-velocity aerosol by forcing the liquid medication through a fine mesh. Faster than conventional jet or ultrasonic nebulizers, VMT devices support shorter treatment times and more precise drug delivery.

Vibrating mesh technology generates fine-particle aerosol

This technology produces a fine-particle, low-velocity aerosol by forcing the liquid medication through a fine mesh. Faster than conventional jet or ultrasonic nebulizers, VMT devices support shorter treatment times and more precise drug delivery.
Long battery life

Long battery life leaves patients free to plan their day

The I-neb is battery-powered with a universal voltage charger. The long battery life provides up to 40 treatments per charge, for freedom and convenience.

Long battery life leaves patients free to plan their day

The I-neb is battery-powered with a universal voltage charger. The long battery life provides up to 40 treatments per charge, for freedom and convenience.

Long battery life leaves patients free to plan their day

The I-neb is battery-powered with a universal voltage charger. The long battery life provides up to 40 treatments per charge, for freedom and convenience.
Specific metering chambers

Specific metering chambers for dosage control

The metering chambers with volumes ranging from 0.25 to 1.7 ml with a residual of about 0.15 ml. This optimizes treatment while reducing waste.

Specific metering chambers for dosage control

The metering chambers with volumes ranging from 0.25 to 1.7 ml with a residual of about 0.15 ml. This optimizes treatment while reducing waste.

Specific metering chambers for dosage control

The metering chambers with volumes ranging from 0.25 to 1.7 ml with a residual of about 0.15 ml. This optimizes treatment while reducing waste.
AAD algorithm

AAD algorithm for adaptive treatment

The I-neb pulses medication delivery into 50 to 80% of each inspiration, based on a rolling average of the last three breaths. Throughout the treatment, the I-neb provides continuous feedback to the patient. Upon successful delivery, the patient receives audible and tactile feedback.

AAD algorithm for adaptive treatment

The I-neb pulses medication delivery into 50 to 80% of each inspiration, based on a rolling average of the last three breaths. Throughout the treatment, the I-neb provides continuous feedback to the patient. Upon successful delivery, the patient receives audible and tactile feedback.

AAD algorithm for adaptive treatment

The I-neb pulses medication delivery into 50 to 80% of each inspiration, based on a rolling average of the last three breaths. Throughout the treatment, the I-neb provides continuous feedback to the patient. Upon successful delivery, the patient receives audible and tactile feedback.

Specifications

General system
General system
Power-Battery Voltage
  • 6W/3.8V
Battery Charger and Charging Lead
  • 100-240 VAC (50-60Hz)
Weight (including battery)
  • 225 g
Dimensions
  • 4.5 cm x 6.5 cm x 15 cm
Storage Temperature Range
  • -20°C to 60°C (-4°F to 140°F)
Operating Temperature Range
  • 10°C to 40°C (50°F to 104°F)
General system
General system
Power-Battery Voltage
  • 6W/3.8V
Battery Charger and Charging Lead
  • 100-240 VAC (50-60Hz)
See all specifications
General system
General system
Power-Battery Voltage
  • 6W/3.8V
Battery Charger and Charging Lead
  • 100-240 VAC (50-60Hz)
Weight (including battery)
  • 225 g
Dimensions
  • 4.5 cm x 6.5 cm x 15 cm
Storage Temperature Range
  • -20°C to 60°C (-4°F to 140°F)
Operating Temperature Range
  • 10°C to 40°C (50°F to 104°F)

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.